Anondita Medicare Limited has secured its first export purchase order worth approximately ₹43.14 crore from Supra Healthcare Johannesburg (Pty) Ltd., South Africa, under the South African Government condom procurement program. This order marks the company's entry into the South African market and validates its manufacturing capabilities. The supplies are expected to be executed by September 30, 2026, strengthening the company's export business.

Order Details

The order comprises the supply and delivery of male condoms equivalent to 50 containers (40-foot containers). This transaction represents a significant milestone as it is the first export purchase order received under the approved South African tender framework. The company was approved as a manufacturer for the supply and delivery of condoms under the said tender for the period commencing from November 1, 2025 and ending on October 31, 2030.

Management Commentary

Mr. Anupam Ghosh, Managing Director, Anondita Medicare Limited, stated that securing the order validates the company's manufacturing excellence and global quality standards. He added that this achievement will enhance the company's presence in international institutional markets.

Company Overview

Anondita Medicare Limited is a manufacturer of condoms and sexual wellness products, operating under the flagship brand “COBRA.” The company focuses on automation-led capacity enhancement and holds certifications including ISO 9001:2015 and ISO 13485:2016.

Anondita Medicare Limited has secured a purchase order worth Rs 3,91,902 from S.S.R Traders for the supply of condoms. The order, received on May 29, 2026, comes from the Nepal-based entity and is expected to be executed within 4-6 weeks from the date of advance receipt. This development follows the company's participation in the Nepal Medical Show 2026, reinforcing its international market presence.

The disclosure was submitted to the National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transaction details comply with SEBI Master Circular No. HO/49/14/14(7)2025CFD-POD2/I/3762/2026 dated January 30, 2026.

Order Details

The company confirmed that neither the promoter group nor group companies hold any interest in the entity awarding the order. Furthermore, the transaction does not qualify as a related party transaction.

The information regarding this order has been uploaded on the company's official website. Bhawna Bisht, Company Secretary and Compliance Officer, signed the disclosure on behalf of anondita medicare .